Jiangsu Hengrui Medicine
600276.SS
#509
Rank
โ‚ฌ36.55 B
Marketcap
5,73ย โ‚ฌ
Share price
-0.27%
Change (1 day)
0.35%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ0.62 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are โ‚ฌ0.62 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.53 B4.55%
2021-12-31โ‚ฌ0.50 B3.05%
2020-12-31โ‚ฌ0.49 B48.11%
2019-12-31โ‚ฌ0.33 B1.7%
2018-12-31โ‚ฌ0.32 B22.26%
2017-12-31โ‚ฌ0.26 B34.74%
2016-12-31โ‚ฌ0.19 B23.81%
2015-12-31โ‚ฌ0.16 B30.04%
2014-12-31โ‚ฌ0.12 B83.37%
2013-12-31โ‚ฌ67.5 M23.62%
2012-12-31โ‚ฌ54.6 M1.42%
2011-12-31โ‚ฌ53.84 M12.26%
2010-12-31โ‚ฌ47.96 M40.49%
2009-12-31โ‚ฌ34.14 M42.74%
2008-12-31โ‚ฌ23.91 M-36.11%
2007-12-31โ‚ฌ37.43 M91.76%
2006-12-31โ‚ฌ19.52 M5.35%
2005-12-31โ‚ฌ18.53 M-10%
2004-12-31โ‚ฌ20.58 M-61.15%
2003-12-31โ‚ฌ53 M16.22%
2002-12-31โ‚ฌ45.6 M-7.67%
2001-12-31โ‚ฌ49.39 M